These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10077182)

  • 61. Safety and immunogenicity of a canarypox-vectored human immunodeficiency virus Type 1 vaccine with or without gp120: a phase 2 study in higher- and lower-risk volunteers.
    Belshe RB; Stevens C; Gorse GJ; Buchbinder S; Weinhold K; Sheppard H; Stablein D; Self S; McNamara J; Frey S; Flores J; Excler JL; Klein M; Habib RE; Duliege AM; Harro C; Corey L; Keefer M; Mulligan M; Wright P; Celum C; Judson F; Mayer K; McKirnan D; Marmor M; Woody G;
    J Infect Dis; 2001 May; 183(9):1343-52. PubMed ID: 11294665
    [TBL] [Abstract][Full Text] [Related]  

  • 62. HIV risk behaviours and situations as perceived by Thai adolescent daughters and their mothers in Bangkok, Thailand.
    Rasamimari A; Dancy B; Smith J
    AIDS Care; 2008 Feb; 20(2):181-7. PubMed ID: 18293126
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Household demand for preventive HIV/AIDS vaccines in Thailand: do husbands' and wives' preferences differ?
    Whittington D; Suraratdecha C; Poulos C; Ainsworth M; Prabhu V; Tangcharoensathien V
    Value Health; 2008; 11(5):965-74. PubMed ID: 18194396
    [TBL] [Abstract][Full Text] [Related]  

  • 64. AIDSVAX (MN) in Bangkok injecting drug users: a report on safety and immunogenicity, including macrophage-tropic virus neutralization.
    Migasena S; Suntharasamai P; Pitisuttithum P; Kitayaporn D; Wasi C; Huang W; Vanichseni S; Koompong C; Kaewkungwal J; Raktham S; Ippolito T; Hanson C; Gregory T; Heyward WL; Berman P; Francis D
    AIDS Res Hum Retroviruses; 2000 May; 16(7):655-63. PubMed ID: 10791876
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Past, present and future of HIV vaccine trials in developing countries.
    Esparza J; Osmanov S; Pattou-Markovic C; Touré C; Chang ML; Nixon S
    Vaccine; 2002 May; 20(15):1897-8. PubMed ID: 11983240
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Factors associated with incarceration and incident human immunodeficiency virus (HIV) infection among injection drug users participating in an HIV vaccine trial in Bangkok, Thailand, 1999-2003.
    Suntharasamai P; Martin M; Vanichseni S; van Griensven F; Mock PA; Pitisuttithum P; Tappero JW; Sangkum U; Kitayaporn D; Gurwith M; Choopanya K;
    Addiction; 2009 Feb; 104(2):235-42. PubMed ID: 19149819
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers. NIAID AIDS Vaccine Evaluation Group.
    Belshe RB; Gorse GJ; Mulligan MJ; Evans TG; Keefer MC; Excler JL; Duliege AM; Tartaglia J; Cox WI; McNamara J; Hwang KL; Bradney A; Montefiori D; Weinhold KJ
    AIDS; 1998 Dec; 12(18):2407-15. PubMed ID: 9875578
    [TBL] [Abstract][Full Text] [Related]  

  • 68. HIV Vaccine Trials: Ethical, Psychological, and Psychological-Social Aspects (1991-1996).
    Giami A; Linard F
    J Acquir Immune Defic Syndr; 2018 Oct; 79 Suppl 1():S51-S58. PubMed ID: 30222705
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Will preventive HIV vaccine efficacy trials be possible with female injection drug users?
    Meyers K; Metzger DS; McLellan AT; Navaline H; Sheon AR; Woody GE
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):577-85. PubMed ID: 8548338
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection.
    Flynn NM; Forthal DN; Harro CD; Judson FN; Mayer KH; Para MF;
    J Infect Dis; 2005 Mar; 191(5):654-65. PubMed ID: 15688278
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Thailand attacks AIDS with two-pronged approach.
    Berman J
    Lancet; 1999 May; 353(9164):1600. PubMed ID: 10334271
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A phase II study of two HIV type 1 envelope vaccines, comparing their immunogenicity in populations at risk for acquiring HIV type 1 infection. AIDS Vaccine Evaluation Group.
    McElrath MJ; Corey L; Montefiori D; Wolff M; Schwartz D; Keefer M; Belshe R; Graham BS; Matthews T; Wright P; Gorse G; Dolin R; Berman P; Francis D; Duliege AM; Bolognesi D; Stablein D; Ketter N; Fast P
    AIDS Res Hum Retroviruses; 2000 Jun; 16(9):907-19. PubMed ID: 10875616
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults.
    Nitayaphan S; Pitisuttithum P; Karnasuta C; Eamsila C; de Souza M; Morgan P; Polonis V; Benenson M; VanCott T; Ratto-Kim S; Kim J; Thapinta D; Garner R; Bussaratid V; Singharaj P; el-Habib R; Gurunathan S; Heyward W; Birx D; McNeil J; Brown AE;
    J Infect Dis; 2004 Aug; 190(4):702-6. PubMed ID: 15272397
    [TBL] [Abstract][Full Text] [Related]  

  • 74. AIDS vaccine fails in Thai trial.
    McCarthy M
    Lancet; 2003 Nov; 362(9397):1728. PubMed ID: 14655660
    [No Abstract]   [Full Text] [Related]  

  • 75. HIV vaccine acceptability among immigrant Thai residents in Los Angeles: a mixed-method approach.
    Lee SJ; Brooks RA; Newman PA; Seiden D; Sangthong R; Duan N
    AIDS Care; 2008 Nov; 20(10):1161-8. PubMed ID: 18608068
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Being "False Positive": An "Inconvenience"? Debates and Questions Regarding the Notion of Vaccine-Induced Seropositivity (VISP) in the Recruitment of Healthy Volunteers for a Preventive Anti-HIV Vaccine Trial.
    Couderc M
    J Acquir Immune Defic Syndr; 2018 Oct; 79 Suppl 1():S20-S29. PubMed ID: 30222702
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Postface: Meaning of the Experiment and Implications of the Experience.
    Le Marcis F
    J Acquir Immune Defic Syndr; 2018 Oct; 79 Suppl 1():S69-S73. PubMed ID: 30222707
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Making sense of AIDSVAX.
    Albrecht H
    AIDS Clin Care; 2003 Apr; 15(4):42. PubMed ID: 12712958
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Psycho-social correlates of health and health behaviors.
    Barth J
    Int J Public Health; 2007; 52(1):4-5. PubMed ID: 17966813
    [No Abstract]   [Full Text] [Related]  

  • 80. Vaccine boosts: balancing response magnitude and character.
    Crowley AR; Ackerman ME
    Lancet HIV; 2020 Apr; 7(4):e217-e219. PubMed ID: 32035517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.